Oppenheimer & Co »

Terns Pharmaceuticals shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $94k 13k 7.51

More positions owned by Oppenheimer & Co

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Servicetitan Shs Cl A (TTAN)

View all positions for Oppenheimer & Co

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Deep Track Capital
Morgan Stanley
Vivo Capital
Commodore Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Candriam Luxembourg S.C.A.
Acorn Capital Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Terns Pharmaceuticals